RxDoctor Payments Data

Lynne Kirkland, MD

Family Medicine · Fairhope, ALNPI 1881643575

Payments from drug & device makers

$13,868in general payments, 2019–2025

Across 771 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • Johnson & Johnson$882
  • Pfizer$841
  • AstraZeneca$636
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$13,77899%
  • Education$901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)135$2,187
Lilly USA, LLC78$1,505
Novo Nordisk98$1,490
Johnson & Johnson(2 entities)45$882
Pfizer53$841
AstraZeneca26$636
Bayer20$544
Merck33$504
Amgen31$472
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$361
Takeda Pharmaceuticals U.S.A., Inc.22$352
Boehringer Ingelheim19$297
Novartis18$263
GSK18$258
Axsome Therapeutics, Inc.12$248
Corcept Therapeutics8$245
Ironshore Pharmaceuticals Inc.8$222
Otsuka America Pharmaceutical, Inc.10$179
Amarin Pharma, Inc.8$170
Corium, LLC8$142
Antares Pharma, Inc.7$139
Paratek Pharmaceuticals, Inc.1$125
Neos Therapeutics, LP7$124
Tris Pharma Inc7$117
Biohaven Pharmaceuticals, Inc.6$101
Clarus Therapeutics Inc.1$94
Mylan Specialty L.p.2$90
Supernus Pharmaceuticals, Inc.5$80
Phathom Pharmaceuticals, Inc.7$77
Esperion Therapeutics, Inc.5$73
Biohaven Pharmaceutical Holding Company Ltd.3$59
Boston Scientific2$58
Astellas Pharma US Inc3$54
Upsher-smith Laboratories LLC2$52
Sumitomo Pharma America, Inc.3$51
Shire North American Group Inc4$50
Inspire Medical Systems, Inc.1$50
Eisai Inc.2$43
Sanofi-aventis U.S. LLC2$42
Lundbeck LLC2$42
Currax Pharmaceuticals LLC3$41
Teva Pharmaceuticals USA, Inc.3$40
Abbott2$40
Jazz Pharmaceuticals Inc.2$38
Exact Sciences2$37
Idorsia Pharmaceuticals US Inc2$33
Optinose US, Inc.2$32
Seqirus USA Inc1$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$27
Shield Therapeutics Inc1$26
Hikma Pharmaceuticals USA2$26
Halozyme Inc1$23
Viatris Specialty LLC1$21
Xeris Pharmaceuticals, Inc.1$20
Tolmar, Inc.1$19
Aytu Biopharma, Inc.1$18
Medtronic1$18
Ironwood Pharmaceuticals, Inc1$16
Endo Pharmaceuticals Inc.1$15
Bausch Health US, LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,868 in reported general payments places this provider in the 95th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$59,098
Medicare patients
114
Services billed
2,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide50$85,148
OzempicSemaglutide51$60,061
JardianceEmpagliflozin13$23,256
MyrbetriqMirabegron18$19,439
TrulicityDulaglutide15$14,229
FarxigaDapagliflozin Propanediol11$7,481
Lidocaine19$5,257
Solifenacin Succinate36$5,209
Rosuvastatin Calcium272$4,191
Duloxetine Hcl159$4,106
Icosapent Ethyl11$3,690
Omeprazole181$3,416
Pregabalin94$2,804
Losartan Potassium205$2,675
Fluticasone Propionate92$2,459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,505$99,37865 claims
Novo NordiskOzempic$1,490$60,06151 claims
Boehringer IngelheimJardiance$297$23,25613 claims
Astellas Pharma US IncMyrbetriq$54$19,43918 claims
AstraZenecaFarxiga$636$7,48111 claims
AbbVieSynthroid$2,187$1,23912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Fairhope

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →